Nonneurotoxic tetralin and indan analogs of 3,4-(methylenedioxy)amphetamine (MDA)

Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and 4,5-(methylenedioxy)-2-aminoindan (3a and 4a, respectively), and 6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulu...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry Vol. 33; no. 2; pp. 703 - 710
Main Authors: Nichols, David E, Brewster, William K, Johnson, Michael P, Oberlender, Robert, Riggs, Robert M
Format: Journal Article
Language:English
Published: United States American Chemical Society 01-02-1990
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and 4,5-(methylenedioxy)-2-aminoindan (3a and 4a, respectively), and 6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulus generalization in the two-lever drug-discrimination paradigm. Two groups of rats were trained to discriminate either LSD tartrate (0.08 mg/kg) from saline, or (+/-)-MDMA.HCl (1.75 mg/kg) from saline. In addition, a 2-aminoindan (5a) and 2-aminotetralin (5b) congener of the hallucinogenic amphetamine 1-(2,5-dimethoxy-4- methylphenyl)-2-aminopropane (DOM) were also evaluated. None of the methylenedioxy compounds substituted in LSD-trained rats, while both 3a and 3b fully substituted in MDMA-trained rats. Compounds 4a and 4b did not substitute in MDMA-trained rats. Compounds 5a and 5b did not substitute in MDMA-trained rats, although 5a substituted in LSD-trained rats, but with relatively low potency compared to its open-chain counterpart. In view of the now well-established serotonin neurotoxicity of 3,4-(methylenedioxy)amphetamine and its N-methyl homologue 1, 3a and 3b were evaluated and compared to 1 for similar toxic effects following a single acute dose of 40 mg/kg sc. Sacrifice at 1 week showed that neither 3a nor 3b depressed rat cortical or hippocampal 5-HT or 5-HIAA levels nor were the number of binding sites (Bmax) depressed for [3H]paroxetine. By contrast, and in agreement with other reports, 1 significantly depressed all three indices of neurotoxicity. These results indicate that 3a and 3b have acute behavioral pharmacology similar to 1 but that they lack similar serotonin neurotoxicity.
AbstractList Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and 4,5-(methylenedioxy)-2-aminoindan (3a and 4a, respectively), and 6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulus generalization in the two-lever drug-discrimination paradigm. Two groups of rats were trained to discriminate either LSD tartrate (0.08 mg/kg) from saline, or (+/-)-MDMA.HCl (1.75 mg/kg) from saline. In addition, a 2-aminoindan (5a) and 2-aminotetralin (5b) congener of the hallucinogenic amphetamine 1-(2,5-dimethoxy-4- methylphenyl)-2-aminopropane (DOM) were also evaluated. None of the methylenedioxy compounds substituted in LSD-trained rats, while both 3a and 3b fully substituted in MDMA-trained rats. Compounds 4a and 4b did not substitute in MDMA-trained rats. Compounds 5a and 5b did not substitute in MDMA-trained rats, although 5a substituted in LSD-trained rats, but with relatively low potency compared to its open-chain counterpart. In view of the now well-established serotonin neurotoxicity of 3,4-(methylenedioxy)amphetamine and its N-methyl homologue 1, 3a and 3b were evaluated and compared to 1 for similar toxic effects following a single acute dose of 40 mg/kg sc. Sacrifice at 1 week showed that neither 3a nor 3b depressed rat cortical or hippocampal 5-HT or 5-HIAA levels nor were the number of binding sites (Bmax) depressed for [3H]paroxetine. By contrast, and in agreement with other reports, 1 significantly depressed all three indices of neurotoxicity. These results indicate that 3a and 3b have acute behavioral pharmacology similar to 1 but that they lack similar serotonin neurotoxicity.
Author Riggs, Robert M
Nichols, David E
Oberlender, Robert
Johnson, Michael P
Brewster, William K
Author_xml – sequence: 1
  givenname: David E
  surname: Nichols
  fullname: Nichols, David E
– sequence: 2
  givenname: William K
  surname: Brewster
  fullname: Brewster, William K
– sequence: 3
  givenname: Michael P
  surname: Johnson
  fullname: Johnson, Michael P
– sequence: 4
  givenname: Robert
  surname: Oberlender
  fullname: Oberlender, Robert
– sequence: 5
  givenname: Robert M
  surname: Riggs
  fullname: Riggs, Robert M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/1967651$$D View this record in MEDLINE/PubMed
BookMark eNptkM9PwjAUgBuDQUBPnk12E6LTdl239Yj4k6BixIuX5q3tZLi1ZB0J_PdCZtSDp_eS78t7yddFLWONRuiY4AuCA3K5KDEmUQiYxnuoQ1iA_TDBYQt1MA4CP4gCeoC6zi0wxpQEtI3ahEdxxEgHvTxZY_SqsrVd59KrdV1BkRsPjPJyo2C3QWE_nGczj56Hfr_U9XxTaKNVbtebAZTLua6hzI32-o_Xw8Eh2s-gcProe_bQ2-3NbHTvT57vHkbDiQ-UhbXPQ6k0SCUTGRNFcSwzkkWccs5olipIZMok45ymLAm5ooFOKUQsAa44pIzRHjpr7srKOlfpTCyrvIRqIwgWuy7iT5etfdLYy1VaavXrNiG23G947mq9_sFQfYoopjETs-mr4O9XjI6nkRhv_dPGB-nEwq6qbSX37-cvg8l62g
CitedBy_id crossref_primary_10_1002_jrs_4957
crossref_primary_10_1002_aoc_1777
crossref_primary_10_1097_FBP_0000000000000237
crossref_primary_10_1016_0014_2999_92_90282_9
crossref_primary_10_1517_13543776_16_5_587
crossref_primary_10_1124_jpet_116_236349
crossref_primary_10_3109_15563650_2011_615318
crossref_primary_10_1002_hup_1255
crossref_primary_10_1039_c4np00010b
crossref_primary_10_1002_dta_310
crossref_primary_10_1016_j_tet_2010_11_066
crossref_primary_10_1016_j_pbb_2004_01_008
crossref_primary_10_1177_1178646919873925
crossref_primary_10_1021_jm9705925
crossref_primary_10_1016_j_tet_2004_06_080
crossref_primary_10_1039_C7CC02608K
crossref_primary_10_3389_fpsyt_2017_00236
crossref_primary_10_1016_0091_3057_91_90106_C
crossref_primary_10_1016_S0091_3057_97_00557_1
crossref_primary_10_1017_S1461145713001405
crossref_primary_10_1039_c3ra46124f
crossref_primary_10_1016_j_pnpbp_2016_04_004
crossref_primary_10_1021_acssynbio_0c00172
crossref_primary_10_1016_S0006_8993_97_00110_8
crossref_primary_10_1016_0014_2999_91_90659_E
crossref_primary_10_1016_S0163_7258_02_00234_6
crossref_primary_10_1002_dta_1434
crossref_primary_10_1016_j_bmcl_2006_11_061
crossref_primary_10_1016_j_jorganchem_2021_122012
crossref_primary_10_1016_S0968_0896_00_00048_1
crossref_primary_10_1039_C5AN00591D
crossref_primary_10_3109_15563650_2011_645952
crossref_primary_10_1002_1098_2299_200010_51_2_52__AID_DDR2_3_0_CO_2_H
crossref_primary_10_1016_S0091_3057_01_00669_4
crossref_primary_10_1021_acs_orglett_1c02767
crossref_primary_10_1016_j_ejphar_2006_07_011
crossref_primary_10_1002_chin_199025136
crossref_primary_10_1002_dta_3622
crossref_primary_10_1016_S0968_0896_03_00053_1
crossref_primary_10_1039_c0ob01214a
crossref_primary_10_1177_0269881120920420
crossref_primary_10_1016_j_toxlet_2013_01_008
crossref_primary_10_1080_00498254_2016_1199919
crossref_primary_10_1016_0014_2999_93_90859_G
crossref_primary_10_1007_s00213_019_05207_1
crossref_primary_10_3390_ijms24031882
crossref_primary_10_1111_j_1749_6632_2000_tb05194_x
crossref_primary_10_1080_00958972_2013_770845
crossref_primary_10_1111_j_2042_7158_1997_tb06758_x
crossref_primary_10_1016_S0379_0738_00_00296_6
crossref_primary_10_1080_00498250600967541
crossref_primary_10_1002_wfs2_1197
crossref_primary_10_1016_j_ejmech_2021_113964
crossref_primary_10_1016_j_neuropharm_2014_01_015
crossref_primary_10_1002_dta_318
crossref_primary_10_1016_0091_3057_91_90017_V
crossref_primary_10_1016_j_tips_2006_10_006
crossref_primary_10_1111_j_1749_6632_1992_tb25975_x
crossref_primary_10_1002_recl_19931120211
crossref_primary_10_1208_aapsj0901001
crossref_primary_10_1016_0091_3057_91_90601_W
crossref_primary_10_1039_C2AN35974J
crossref_primary_10_1111_j_1747_0285_2009_00845_x
crossref_primary_10_1002_hup_2298
crossref_primary_10_1016_j_neuropharm_2017_10_003
crossref_primary_10_1016_0006_2952_96_00482_0
crossref_primary_10_1002_jhet_5570280325
crossref_primary_10_1038_npp_2013_331
crossref_primary_10_1016_j_bcp_2014_01_024
ContentType Journal Article
DBID BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1021/jm00164a037
DatabaseName Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-4804
EndPage 710
ExternalDocumentID 10_1021_jm00164a037
1967651
ark_67375_TPS_9ZB53JP6_J
b638488246
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NIDA NIH HHS
  grantid: DA-04758
GroupedDBID -
08R
1WB
3EH
53G
55
55A
5GY
5RE
5VS
9M8
AABXI
ABFLS
ABMVS
ABOCM
ABPTK
ACGFS
ACJ
ACS
AENEX
AFFNX
AGXLV
AJYGW
ALMA_UNASSIGNED_HOLDINGS
ANTXH
AQSVZ
BAANH
CS3
DU5
F5P
GJ
HR
JG
JG~
L7B
LG6
MVM
NHB
OHT
P2P
RNS
ROL
TN5
W1F
WH7
X
X7M
XFK
YZZ
ZE2
ZGI
---
-~X
.55
.GJ
.HR
.K2
6TJ
AAHBH
ABHMW
ABJNI
ACGFO
BSCLL
CUPRZ
EBS
GGK
IH2
VG9
XSW
YQT
1KJ
3O-
4.4
6P2
7~N
AAYOK
ABQRX
ABTAH
ABUCX
ADHLV
AEESW
AFEFF
AHGAQ
CGR
CUY
CVF
ECM
ED~
EIF
EJD
GNL
IH9
IHE
NPM
UBC
UI2
VF5
ZY4
AAYXX
CITATION
ID FETCH-LOGICAL-a354t-94cdeacdc8c71d307cf1f6939953fbda8cb5c5993b5849d32eb3a658a9d9ab553
IEDL.DBID ACS
ISSN 0022-2623
IngestDate Fri Aug 23 02:53:20 EDT 2024
Sat Sep 28 08:33:45 EDT 2024
Wed Oct 30 09:48:20 EDT 2024
Thu Aug 27 13:42:11 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a354t-94cdeacdc8c71d307cf1f6939953fbda8cb5c5993b5849d32eb3a658a9d9ab553
Notes istex:31232F1E9128B0F3433606DC8BA73A4817F12928
ark:/67375/TPS-9ZB53JP6-J
PMID 1967651
PageCount 8
ParticipantIDs crossref_primary_10_1021_jm00164a037
pubmed_primary_1967651
istex_primary_ark_67375_TPS_9ZB53JP6_J
acs_journals_10_1021_jm00164a037
ProviderPackageCode JG~
55A
AABXI
ACS
ACJ
AGXLV
ABMVS
1WB
BAANH
AQSVZ
W1F
ANTXH
PublicationCentury 1900
PublicationDate 1990-02-01
PublicationDateYYYYMMDD 1990-02-01
PublicationDate_xml – month: 02
  year: 1990
  text: 1990-02-01
  day: 01
PublicationDecade 1990
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of medicinal chemistry
PublicationTitleAlternate J. Med. Chem
PublicationYear 1990
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
SSID ssj0003123
Score 1.6404645
Snippet Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and...
SourceID crossref
pubmed
istex
acs
SourceType Aggregation Database
Index Database
Publisher
StartPage 703
SubjectTerms 3,4-Methylenedioxyamphetamine - analogs & derivatives
3,4-Methylenedioxyamphetamine - chemical synthesis
Amphetamines - chemical synthesis
Animals
Behavior, Animal - drug effects
Catecholamines - metabolism
Cerebral Cortex - metabolism
Hippocampus - metabolism
Indans
Lysergic Acid Diethylamide
N-Methyl-3,4-methylenedioxyamphetamine
Paroxetine
Piperidines - metabolism
Psychotropic Drugs - chemical synthesis
Psychotropic Drugs - pharmacology
Rats
Serotonin - metabolism
Structure-Activity Relationship
Tetrahydronaphthalenes
Title Nonneurotoxic tetralin and indan analogs of 3,4-(methylenedioxy)amphetamine (MDA)
URI http://dx.doi.org/10.1021/jm00164a037
https://api.istex.fr/ark:/67375/TPS-9ZB53JP6-J/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/1967651
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swED_W9mF72bpuZem2oocutBCzyPqyHru0pRRWMpLB2IuR9QHdqF1iB5L_fic7aWhZ2d78IAtxJ93vd6e7E8CRtLTQivpEDjlPePAhyahMEwRzOmReaR9iwO1yoq5_ZGfnsU3Opydu8FP6-ddt2wbKDJnagp1UIUeIDGg0uTe4jKZs3RQ8RThfleE9-jnCj60fwM9OlOTiEaFsgeXi1X8uaRderpgjOe1U_Rqe-XIPno_WD7btQX_ctaFeDsh0U1VVD0ifjDcNqpdv4Nt1zG6Zz6qmWtxY0vg22lESUzoSXfT4FWM6NakCYQOeHMd3ppeIT4h01WJ5YnAL-MbcIkMlx1_PTk_ewveL8-noMlk9rZAYJniTaG4dmlxnM6uow3NuAw1SxzpXFgpnMlsIK5C7FEhQtGMp-twGyYrRTptCCLYP22VV-ndAfIFGIHgruee88CYTyAAzpbw03ngXekBQ7vnqaNR5e-udotexEWIPjtZKye-6Jht_H9ZvFXY_xsx-x7w0JfLpeJLrn18EuxrL_KoH-51GN7NpqaSgB_9ey3t4QRGhu8TsD7DdzOb-I2zVbn7Y7ro_h5jNOA
link.rule.ids 315,782,786,2769,27085,27933,27934,56747,56797
linkProvider American Chemical Society
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFD6s7UP30m3dyrKrHkpoIWaRdbH12KUtWdeGjGQw9mJkXWAbtUvsQPLvd2QnNSuDsTc_yELoSPo-HZ3zHYBjaWiuEuoiOeQ84t75KKUyjhDM6ZC5RDkfHG7jWTL5lp5fBJmcwTYXBgdRYU9V84jfqQvQDz9vGzUoPWTJDuwJiTQ4EKHR7P7cZTRmW23wGFF9k4334OeAQqb6A4X2woSuHvDKBl8un_zfyJ7CwYZHkrPW8M_gkSsOYX-0Ld92CP1pK0q9HpB5l2NVDUifTDu56vVz-DIJsS7LRVmXqx-G1K7xfRREF5aEC3v4Ch6eipSesAGPTkLV6TWiFeJeuVqfalwQrta3yFfJyc352ekL-Hp5MR-No02hhUgzwetIcWPxALYmNQm1uOuNp16qkPXKfG51anJhBDKZHOmKsizGG7hG6qKVVToXgh3BblEW7iUQl-OR4J2R3HGeO50K5INpkjipnXbW94DgHGabjVJlzRt4jHeQbhJ7cLy1TXbXSm78vVm_sdt9G734FaLUEpHNp7NMff8o2NVUZlc9OGoN2_WmZCIFffXvsbyH_fH85jq7_jT5_BoeU8TuNmT7DezWi6V7CzuVXb5rFuJvT1nVpQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFBZrC1tfdulWml31UEILMY2sm_WYJQ1dtwWPZDD2YmRdYBu1S-xA8u93ZDsNK4OxNz_I4nB0pO87ks4nhE6FIbmSxEViyFjEvPNRQkQcAZiTIXVSOR823K7mcvYtmVwGmZzhthYGjKigp6o5xA-z-tb6TmGAXPy8aRSh9JDKPXTAhVQh3RqN53drLyUx3eqDx4DsXUXevZ8DEpnqDyQ6CE5d3-OWDcZMn_y_dU_R445P4lEbAM_QA1ccoUfj7TNuR6iftuLUmwFe7GqtqgHu43QnW715jr7Mwp2X1bKsy_UPg2vX7IEUWBcWh8Q9fIWdngqXHtMBi87C69MbQC3Av3K9OdcQGK7WN8Bb8dnnyej8Bfo6vVyMr6LuwYVIU87qSDFjYSG2JjGSWJj9xhMvVKh-pT63OjE5NxwYTQ60RVkaQyaugcJoZZXOOafHaL8oC3eCsMthafDOCOYYy51OOPDCREontNPO-h7C4MesmzBV1pyFx5CL7JzYQ6fb8cluW-mNvzfrN2N310Yvf4XbapJni3Seqe_vOb1ORXbdQ8ft4O56U0IKTl7-25Z36GE6mWafPsw-vkKHBCC8vbn9Gu3Xy5V7g_Yqu3rbxOJvfULYKA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nonneurotoxic+tetralin+and+indan+analogues+of+3%2C4-%28methylenedioxy%29amphetamine+%28MDA%29&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=Nichols%2C+D+E&rft.au=Brewster%2C+W+K&rft.au=Johnson%2C+M+P&rft.au=Oberlender%2C+R&rft.date=1990-02-01&rft.issn=0022-2623&rft.volume=33&rft.issue=2&rft.spage=703&rft_id=info:doi/10.1021%2Fjm00164a037&rft_id=info%3Apmid%2F1967651&rft.externalDocID=1967651
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon